Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of $2.17 billion as of June 13, 2025. Its market cap has increased by 42.24% in one year.

Market Cap

2.17B

Enterprise Value

1.97B

Revenue

181.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.14

Market Cap Chart

Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 76.19M to 2.17B, an increase of 2,748.92%. That is a compound annual growth rate of 11.58%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	2.17B	7.21%
Dec 31, 2024	2.02B	62.59%
Dec 29, 2023	1.25B	10.35%
Dec 30, 2022	1.13B	-56.28%
Dec 31, 2021	2.58B	61.40%
Dec 31, 2020	1.60B	-12.69%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Veradigm	747.25M
Elite Pharmaceuticals	734.44M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	443.91M
Glass House Brands	388.80M
Northwest Biotherapeutics	377.72M

Market Cap Rankings